{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:55:10Z","timestamp":1790283310510,"version":"4.1.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["L3-2620, J7-2603, P3-0387"],"award-info":[{"award-number":["L3-2620, J7-2603, P3-0387"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10096-026-05561-x","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T01:04:26Z","timestamp":1781571866000},"page":"2859-2873","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Vancomycin and phage COP-80B combination therapy for Staphylococcus epidermidis periprosthetic joint infections: a preclinical mouse study"],"prefix":"10.1007","volume":"45","author":[{"given":"Vida","family":"\u0160tilec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Maru\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Motaln","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Gregori\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ur\u0161ka","family":"Draksler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0161a","family":"\u010cater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jani","family":"Izlakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nika","family":"Jane\u017e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihard","family":"Treb\u0161e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Horvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matja\u017e","family":"Peterka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"5561_CR1","doi-asserted-by":"publisher","DOI":"10.1302\/2633-1462.63.BJO-2024-0225.R1","volume":"6","author":"V Alt","year":"2025","unstructured":"Alt V, Szymski D, Rupp M et al (2025) The health-economic burden of hip and knee periprosthetic joint infections in Europe: a comprehensive analysis following primary arthroplasty. Bone Jt Open 6:298. https:\/\/doi.org\/10.1302\/2633-1462.63.BJO-2024-0225.R1","journal-title":"Bone Jt Open"},{"key":"5561_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1056\/NEJMRA2203477","volume":"388","author":"R Patel","year":"2023","unstructured":"Patel R (2023) Periprosthetic Joint Infection. N Engl J Med 388:251\u2013262. https:\/\/doi.org\/10.1056\/NEJMRA2203477","journal-title":"N Engl J Med"},{"key":"5561_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cmi.2021.06.006","volume":"28","author":"DBG Tai","year":"2022","unstructured":"Tai DBG, Patel R, Abdel MP et al (2022) Microbiology of hip and knee periprosthetic joint infections: a database study. Clin Microbiol Infect 28:255\u2013259. https:\/\/doi.org\/10.1016\/j.cmi.2021.06.006","journal-title":"Clin Microbiol Infect"},{"key":"5561_CR4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nrmicro2182","volume":"7","author":"M Otto","year":"2009","unstructured":"Otto M (2009) Staphylococcus epidermidis - the accidental pathogen. Nat Rev Microbiol 7:555\u2013567. https:\/\/doi.org\/10.1038\/nrmicro2182","journal-title":"Nat Rev Microbiol"},{"key":"5561_CR5","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1128\/CMR.00111-13","volume":"27","author":"AJ Tande","year":"2014","unstructured":"Tande AJ, Patel R (2014) Prosthetic joint infection. Clin Microbiol Rev 27:302\u2013345. https:\/\/doi.org\/10.1128\/CMR.00111-13","journal-title":"Clin Microbiol Rev"},{"key":"5561_CR6","doi-asserted-by":"publisher","DOI":"10.7150\/JBJI.43705","volume":"5","author":"J Bongers","year":"2020","unstructured":"Bongers J, Jacobs AME, Smulders K et al (2020) Reinfection and re-revision rates of 113 two-stage revisions in infected TKA. J Bone Joint Infect 5:137. https:\/\/doi.org\/10.7150\/JBJI.43705","journal-title":"J Bone Joint Infect"},{"key":"5561_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz452","volume":"6","author":"CE Kandel","year":"2019","unstructured":"Kandel CE, Jenkinson R, Daneman N et al (2019) Predictors of treatment failure for hip and knee prosthetic joint infections in the setting of 1-and 2-stage exchange arthroplasty: a multicenter retrospective cohort. Open Forum Infect Dis 6:ofz452. https:\/\/doi.org\/10.1093\/ofid\/ofz452","journal-title":"Open Forum Infect Dis"},{"key":"5561_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.591021","volume":"11","author":"JD Van Belleghem","year":"2020","unstructured":"Van Belleghem JD, Manasherob R, Mi\u0229dzybrodzki R et al (2020) The rationale for using bacteriophage to treat and prevent periprosthetic joint infections. Front Microbiol 11:591021. https:\/\/doi.org\/10.3389\/fmicb.2020.591021","journal-title":"Front Microbiol"},{"key":"5561_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.570572","volume":"7","author":"T Ferry","year":"2020","unstructured":"Ferry T, Kolenda C, Batailler C et al (2020) Phage therapy as adjuvant to conservative surgery and antibiotics to salvage patients with relapsing S. aureus prosthetic knee infection. Front Med 7:721. https:\/\/doi.org\/10.3389\/fmed.2020.570572","journal-title":"Front Med"},{"key":"5561_CR10","doi-asserted-by":"publisher","first-page":"e1463","DOI":"10.1093\/CID\/CIAC694","volume":"76","author":"JB Doub","year":"2023","unstructured":"Doub JB, Johnson AJ, Nandi S et al (2023) Experience using adjuvant bacteriophage therapy for the treatment of 10 recalcitrant periprosthetic joint infections: A case series. Clin Infect Dis 76:e1463\u2013e1466. https:\/\/doi.org\/10.1093\/CID\/CIAC694","journal-title":"Clin Infect Dis"},{"key":"5561_CR11","doi-asserted-by":"publisher","unstructured":"Onallah H, Hazan R, Nir-Paz R et al (2023) Compassionate Use of Bacteriophages for Failed Persistent Infections During the First 5 Years of the Israeli Phage Therapy Center. Open Forum Infect Dis 10. https:\/\/doi.org\/10.1093\/OFID\/OFAD221","DOI":"10.1093\/OFID\/OFAD221"},{"key":"5561_CR12","doi-asserted-by":"publisher","first-page":"S407","DOI":"10.1093\/CID\/CIAD533","volume":"77","author":"GA Suh","year":"2023","unstructured":"Suh GA, Ferry T, Abdel MP (2023) Phage therapy as a novel therapeutic for the treatment of bone and joint infections. Clin Infect Dis 77:S407\u2013S415. https:\/\/doi.org\/10.1093\/CID\/CIAD533","journal-title":"Clin Infect Dis"},{"key":"5561_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIBIOTICS14020114","volume":"14","author":"DI Munteanu","year":"2025","unstructured":"Munteanu DI, Dunn J, Apjok G et al (2025) Phage therapy for orthopaedic infections: The first three cases from the United Kingdom. Antibiotics 14:114. https:\/\/doi.org\/10.3390\/ANTIBIOTICS14020114","journal-title":"Antibiotics"},{"key":"5561_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02071-21","author":"GA Suh","year":"2022","unstructured":"Suh GA, Lodise TP, Tamma PD et al (2022) Considerations for the use of phage therapy in clinical practice. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.02071-21","journal-title":"Antimicrob Agents Chemother"},{"key":"5561_CR15","doi-asserted-by":"crossref","unstructured":"Ferry T (2024) A review of phage therapy for bone and joint Infections. Methods in Molecular Biology. Humana, New York, NY, pp 207\u2013235","DOI":"10.1007\/978-1-0716-3523-0_14"},{"key":"5561_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s15010-021-01675-w","volume":"50","author":"JB Doub","year":"2022","unstructured":"Doub JB, Wilson E (2022) Observed transaminitis with a unique bacteriophage therapy protocol to treat recalcitrant Staphylococcal biofilm infections. Infection 50:281\u2013283. https:\/\/doi.org\/10.1007\/s15010-021-01675-w","journal-title":"Infection"},{"key":"5561_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9050241","volume":"9","author":"JB Doub","year":"2020","unstructured":"Doub JB, Ng VY, Johnson AJ et al (2020) Salvage bacteriophage therapy for a chronic MRSA prosthetic joint infection. Antibiotics 9:241. https:\/\/doi.org\/10.3390\/antibiotics9050241","journal-title":"Antibiotics"},{"key":"5561_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/JBM.A.31376","volume":"84A","author":"B Laure","year":"2008","unstructured":"Laure B, Besnier JM, Bergemer-Fouquet AM et al (2008) Effect of hydroxyapatite coating and polymethylmethacrylate on stainless steel implant-site infection with Staphylococcus epidermidis in a sheep model. J Biomed Mater Res A 84A:92\u201398. https:\/\/doi.org\/10.1002\/JBM.A.31376","journal-title":"J Biomed Mater Res A"},{"key":"5561_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0102760","volume":"9","author":"H Zhai","year":"2014","unstructured":"Zhai H, Pan J, Pang E, Bai B (2014) Lavage with allicin in combination with vancomycin inhibits biofilm formation by Staphylococcus epidermidis in a rabbit model of prosthetic joint infection. PLoS One 9:e102760. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0102760","journal-title":"PLoS One"},{"key":"5561_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00303-21","author":"J Wei","year":"2021","unstructured":"Wei J, Wen Y, Tong K et al (2021) Local application of vancomycin in one-stage revision of prosthetic joint infection caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/aac.00303-21","journal-title":"Antimicrob Agents Chemother"},{"key":"5561_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/V16111800","volume":"16","author":"J Young","year":"2024","unstructured":"Young J, Shariyate MJ, Misra P et al (2024) Assessment of bacteriophage pharmacokinetic parameters after intra-articular delivery in a rat prosthetic joint infection model. Viruses 16:1800. https:\/\/doi.org\/10.3390\/V16111800","journal-title":"Viruses"},{"key":"5561_CR22","doi-asserted-by":"publisher","unstructured":"Morris JL, Letson HL, Grant A et al (2019) Experimental model of peri-prosthetic infection of the knee caused by Staphylococcus aureus using biomaterials representative of modern TKA.\u00a0Biol Open 8.\u00a0https:\/\/doi.org\/10.1242\/BIO.045203\/222836","DOI":"10.1242\/BIO.045203\/222836"},{"key":"5561_CR23","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.16.00815","author":"AV Carli","year":"2017","unstructured":"Carli AV, Bhimani S, Yang X et al (2017) Quantification of peri-implant bacterial load and in vivo biofilm formation in an innovative, clinically representative mouse model of periprosthetic joint infection. J Bone Joint Surg Am. https:\/\/doi.org\/10.2106\/JBJS.16.00815","journal-title":"J Bone Joint Surg Am"},{"key":"5561_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0012580","volume":"5","author":"NM Bernthal","year":"2010","unstructured":"Bernthal NM, Stavrakis AI, Billi F et al (2010) A mouse model of post-arthroplasty Staphylococcus aureus joint infection to evaluate in vivo the efficacy of antimicrobial implant coatings. PLoS One 5:e12580. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0012580","journal-title":"PLoS One"},{"key":"5561_CR25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.22203\/ECM.V042A22","volume":"42","author":"C Guarch-P\u00e9rez","year":"2021","unstructured":"Guarch-P\u00e9rez C, Riool M, Zaat SAJ (2021) Current osteomyelitis mouse models, a systematic review. Eur Cell Mater 42:334\u2013374. https:\/\/doi.org\/10.22203\/ECM.V042A22","journal-title":"Eur Cell Mater"},{"key":"5561_CR26","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1021\/acsbiomaterials.4c02331","volume":"11","author":"F Chen","year":"2025","unstructured":"Chen F, Schiffer NE, Song J (2025) Animal Models of Orthopedic Implant-Associated Infections and Revisions. ACS Biomater Sci Eng 11:2052\u20132068. https:\/\/doi.org\/10.1021\/acsbiomaterials.4c02331","journal-title":"ACS Biomater Sci Eng"},{"key":"5561_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mbio.01462-20","volume":"11","author":"C Gu Liu","year":"2020","unstructured":"Gu Liu C, Green SI, Min L et al (2020) Phage-antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry. mBio 11:1\u201319. https:\/\/doi.org\/10.1128\/mbio.01462-20","journal-title":"mBio"},{"key":"5561_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/SPECTRUM.03219-23","author":"S De Soir","year":"2023","unstructured":"De Soir S, Par\u00e9e H, Hidayatul N et al (2023) Exploiting phage-antibiotic synergies to disrupt Pseudomonas aeruginosa PAO1 biofilms in the context of orthopedic infections. Microbiol Spectr. https:\/\/doi.org\/10.1128\/SPECTRUM.03219-23","journal-title":"Microbiol Spectr"},{"key":"5561_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/J.EBIOM.2022.104045","volume":"80","author":"FL Gordillo Altamirano","year":"2022","unstructured":"Gordillo Altamirano FL, Kostoulias X, Subedi D et al (2022) Phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study. EBioMedicine 80:104045. https:\/\/doi.org\/10.1016\/J.EBIOM.2022.104045","journal-title":"EBioMedicine"},{"key":"5561_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226574","author":"JL Morris","year":"2019","unstructured":"Morris JL, Letson HL, Elliott L et al (2019) Evaluation of bacteriophage as an adjunct therapy for treatment of peri-prosthetic joint infection caused by Staphylococcus aureus. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0226574","journal-title":"PLoS One"},{"key":"5561_CR31","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/JOR.70029","volume":"43","author":"SC Herren","year":"2025","unstructured":"Herren SC, Karau MJ, Guarin Perez SF et al (2025) Activity of phage and vancomycin in a murine Staphylococcus aureus periprosthetic joint infection model managed with debridement and implant retention. J Orthop Res 43:1767\u20131775. https:\/\/doi.org\/10.1002\/JOR.70029","journal-title":"J Orthop Res"},{"key":"5561_CR32","doi-asserted-by":"publisher","unstructured":"Duarte AC, Fern\u00e1ndez L, Rodr\u00edguez A, Garc\u00eda P (2025) A new bacteriophage infecting Staphylococcus epidermidis with potential for removing biofilms by combination with chimeric lysin CHAPSH3b and vancomycin.\u00a0mSphere 10:e01014-24.\u00a0 https:\/\/doi.org\/10.1128\/MSPHERE.01014-24","DOI":"10.1128\/MSPHERE.01014-24"},{"key":"5561_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2025.199592","volume":"357","author":"V \u0160tilec","year":"2025","unstructured":"\u0160tilec V, Maru\u0161i\u0107 M, Jane\u017e N et al (2025) Preparation and pharmacokinetic evaluation of Staphylococcus phage COP-80B for treatment of periprosthetic joint infections in a mouse model. Virus Res 357:199592. https:\/\/doi.org\/10.1016\/j.virusres.2025.199592","journal-title":"Virus Res"},{"key":"5561_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1169135","volume":"13","author":"V \u0160trancar","year":"2023","unstructured":"\u0160trancar V, Maru\u0161i\u0107 M, Tu\u0161ar J et al (2023) Isolation and in vitro characterization of novel S. epidermidis phages for therapeutic applications. Front Cell Infect Microbiol 13:1169135. https:\/\/doi.org\/10.3389\/fcimb.2023.1169135","journal-title":"Front Cell Infect Microbiol"},{"key":"5561_CR35","unstructured":"National Centre for Disease Control (NCDC) I-NP on AR (AMR) C (2023) Standard Operating Procedure. Broth-microdilution Vancomycin Susceptibility Test - Aerobic Gram-Positive Cocci"},{"key":"5561_CR36","doi-asserted-by":"crossref","unstructured":"Kropinski AM, Mazzocco A, Waddell TE et al (2009) Enumeration of Bacteriophages by Double Agar Overlay Plaque Assay. In: Clokie MRJ, Kropinski AM (eds) Bacteriophages: Methods and Protocols, Volume 1: Isolation, Characterization, and Interactions. Humana, Totowa, NJ, pp 69\u201376","DOI":"10.1007\/978-1-60327-164-6_7"},{"key":"5561_CR37","doi-asserted-by":"crossref","unstructured":"Mazzocco A, Waddell TE, Lingohr E, Johnson RP (2009) Enumeration of Bacteriophages Using the Small Drop Plaque Assay System. In: Clokie MRJ, Kropinski AM (eds) Methods in molecular biology. Humana, pp 81\u201385","DOI":"10.1007\/978-1-60327-164-6_9"},{"key":"5561_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/MBO3.558","volume":"7","author":"D Nabergoj","year":"2018","unstructured":"Nabergoj D, Modic P, Podgornik A (2018) Effect of bacterial growth rate on bacteriophage population growth rate. Microbiologyopen 7:e00558. https:\/\/doi.org\/10.1002\/MBO3.558","journal-title":"Microbiologyopen"},{"key":"5561_CR39","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.2106\/JBJS.N.01052","volume":"97","author":"X Yang","year":"2014","unstructured":"Yang X, Ricciardi BF, Dvorzhinskiy A et al (2014) Intermittent parathyroid hormone enhances cancellous osseointegration of a novel murine tibial implant. J Bone Joint Surg - Am Volume 97:1074\u20131083. https:\/\/doi.org\/10.2106\/JBJS.N.01052","journal-title":"J Bone Joint Surg - Am Volume"},{"key":"5561_CR40","doi-asserted-by":"publisher","first-page":"756","DOI":"10.2340\/17453674.2022.4579","volume":"93","author":"JB Doub","year":"2022","unstructured":"Doub JB, Shishido A, Srikumaran U et al (2022) Salphage: salvage bacteriophage therapy for a recalcitrant Klebsiella pneumoniae prosthetic shoulder infection - a case report. Acta Orthop 93:756\u2013759. https:\/\/doi.org\/10.2340\/17453674.2022.4579","journal-title":"Acta Orthop"},{"key":"5561_CR41","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1128\/aac.00062-10","volume":"54","author":"JL Crandon","year":"2010","unstructured":"Crandon JL, Kuti JL, Nicolau DP (2010) Comparative efficacies of human simulated exposures of telavancin and vancomycin against methicillin-resistant Staphylococcus aureus with a range of vancomycin MICs in a murine pneumonia model. Antimicrob Agents Chemother 54:5115\u20135119. https:\/\/doi.org\/10.1128\/aac.00062-10","journal-title":"Antimicrob Agents Chemother"},{"key":"5561_CR42","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1128\/JB.173.2.697-703.1991","volume":"173","author":"WG Weisburg","year":"1991","unstructured":"Weisburg WG, Barns SM, Pelletier DA, Lane DJ (1991) 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 173:697\u2013703. https:\/\/doi.org\/10.1128\/JB.173.2.697-703.1991","journal-title":"J Bacteriol"},{"key":"5561_CR43","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1073\/PNAS.82.20.6955","volume":"82","author":"DJ Lane","year":"1985","unstructured":"Lane DJ, Pace B, Olsen GJ et al (1985) Rapid determination of 16S ribosomal RNA sequences for phylogenetic analyses. Proc Natl Acad Sci U S A 82:6955\u20136959. https:\/\/doi.org\/10.1073\/PNAS.82.20.6955","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5561_CR44","doi-asserted-by":"crossref","unstructured":"Adams MH (1959) In: Bacteriophages (ed) Methods of study of bacterial viruses. Inter-Science, New York, pp 443\u2013552","DOI":"10.5962\/bhl.title.6966"},{"key":"5561_CR45","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"2","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang A-G, Buchner A (2007) G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2:175\u2013191","journal-title":"Behav Res Methods"},{"key":"5561_CR46","doi-asserted-by":"publisher","DOI":"10.21105\/JOSS.03021","volume":"6","author":"ML Waskom","year":"2021","unstructured":"Waskom ML (2021) seaborn: statistical data visualization. J Open Source Softw 6:3021. https:\/\/doi.org\/10.21105\/JOSS.03021","journal-title":"J Open Source Softw"},{"key":"5561_CR47","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter JD (2007) Matplotlib: A 2D graphics environment. Comput Sci Eng 9:90\u201395. https:\/\/doi.org\/10.1109\/MCSE.2007.55","journal-title":"Comput Sci Eng"},{"key":"5561_CR48","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1006\/jmcc.1998.0655","volume":"30","author":"BK Slinker","year":"1998","unstructured":"Slinker BK (1998) The Statistics of Synergism. J Mol Cell Cardiol 30:723\u2013731","journal-title":"J Mol Cell Cardiol"},{"key":"5561_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/S00264-024-06295-1","volume":"48","author":"S Yang","year":"2024","unstructured":"Yang S, Mukh AA, Abdelatif E et al (2024) Bacteriophage therapy as an innovative strategy for the treatment of Periprosthetic Joint Infection: a systematic review. Int Orthop 48:2809. https:\/\/doi.org\/10.1007\/S00264-024-06295-1","journal-title":"Int Orthop"},{"key":"5561_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0157626","volume":"11","author":"S Kaur","year":"2016","unstructured":"Kaur S, Harjai K, Chhibber S (2016) In vivo assessment of phage and linezolid based implant coatings for treatment of methicillin resistant S. aureus (MRSA) mediated orthopaedic device related infections. PLoS One 11:e0157626. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0157626","journal-title":"PLoS One"},{"key":"5561_CR51","doi-asserted-by":"publisher","first-page":"81","DOI":"10.21775\/CIMB.040.081","volume":"40","author":"K Danis-Wlodarczyk","year":"2020","unstructured":"Danis-Wlodarczyk K, D\u0105browska K, Abedon ST (2020) Phage therapy: The pharmacology of antibacterial viruses. Curr Issues Mol Biol 40:81\u2013164. https:\/\/doi.org\/10.21775\/CIMB.040.081","journal-title":"Curr Issues Mol Biol"},{"key":"5561_CR52","doi-asserted-by":"publisher","first-page":"e00040","DOI":"10.1128\/mSphere.00040-17","volume":"2","author":"K Cater","year":"2017","unstructured":"Cater K, Dandu VS, Bari SMN et al (2017) A novel Staphylococcus podophage encodes a unique lysin with unusual modular design. mSphere 2:e00040\u2013e00017. https:\/\/doi.org\/10.1128\/mSphere.00040-17","journal-title":"mSphere"},{"key":"5561_CR53","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1128\/AEM.03560-14","volume":"81","author":"D Guti\u00e9rrez","year":"2015","unstructured":"Guti\u00e9rrez D, Vandenheuvel D, Mart\u00ednez B et al (2015) Two phages, phiIPLA-RODI and phiIPLA-C1C, lyse mono-and dual-species staphylococcal biofilms. Appl Environ Microbiol 81:3336\u20133348. https:\/\/doi.org\/10.1128\/AEM.03560-14","journal-title":"Appl Environ Microbiol"},{"key":"5561_CR54","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1099\/vir.0.060590-0","volume":"95","author":"LDR Melo","year":"2014","unstructured":"Melo LDR, Sillankorva S, Ackermann HW et al (2014) Isolation and characterization of a new Staphylococcus epidermidis broad-spectrum bacteriophage. J Gen Virol 95:506\u2013515. https:\/\/doi.org\/10.1099\/vir.0.060590-0","journal-title":"J Gen Virol"},{"key":"5561_CR55","doi-asserted-by":"publisher","unstructured":"Valente LG, Pitton M, F\u00fcrholz M et al (2021) Isolation and characterization of bacteriophages from the human skin microbiome that infect Staphylococcus epidermidis. FEMS Microbes 2.\u00a0xTable 003.\u00a0https:\/\/doi.org\/10.1093\/femsmc\/xtab003","DOI":"10.1093\/femsmc\/xtab003"},{"key":"5561_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1386245","volume":"15","author":"K Parmar","year":"2024","unstructured":"Parmar K, Fackler JR, Rivas Z et al (2024) A comparison of phage susceptibility testing with two liquid high-throughput methods. Front Microbiol 15:1386245. https:\/\/doi.org\/10.3389\/fmicb.2024.1386245","journal-title":"Front Microbiol"},{"key":"5561_CR57","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/S2666-5247(21)00127-0","volume":"2","author":"D Gelman","year":"2021","unstructured":"Gelman D, Yerushalmy O, Alkalay-Oren S et al (2021) Clinical phage microbiology: a suggested framework and recommendations for the in-vitro matching steps of phage therapy. Lancet Microbe 2:e555\u2013e563. https:\/\/doi.org\/10.1016\/S2666-5247(21)00127-0","journal-title":"Lancet Microbe"},{"key":"5561_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/S12941-025-00783-X","volume":"24","author":"AA Zanaty","year":"2025","unstructured":"Zanaty AA, Dishisha T, El-Sayed-Ahmed MAEG et al (2025) Characterization, genomic analysis and preclinical evaluation of the lytic Staphylococcus bacteriophage PSK against methicillin-resistant Staphylococcus aureus wound isolate. Ann Clin Microbiol Antimicrob 24:17. https:\/\/doi.org\/10.1186\/S12941-025-00783-X","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"5561_CR59","doi-asserted-by":"publisher","unstructured":"Martinez-Soto CE, Cuci\u0107 S, Lin JT et al (2021) PHIDA: A high throughput turbidimetric data analytic tool to compare host range profiles of bacteriophages isolated using different enrichment methods. Viruses 13. https:\/\/doi.org\/10.3390\/V13112120\/S1","DOI":"10.3390\/V13112120\/S1"},{"key":"5561_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/PH15020177","volume":"15","author":"J Schoeffel","year":"2022","unstructured":"Schoeffel J, Wang EW, Gill D et al (2022) Successful use of salvage bacteriophage therapy for a recalcitrant MRSA knee and hip prosthetic joint infection. Pharmaceuticals 15:177. https:\/\/doi.org\/10.3390\/PH15020177","journal-title":"Pharmaceuticals"},{"key":"5561_CR61","doi-asserted-by":"publisher","unstructured":"Park KH, Greenwood-Quaintance KE, Schuetz AN et al (2017) Activity of tedizolid in methicillin-resistant Staphylococcus epidermidis experimental foreign body-associated osteomyelitis. Antimicrob Agents Chemother 61(2):e01644-16. https:\/\/doi.org\/10.1128\/aac.01644-16","DOI":"10.1128\/aac.01644-16"},{"key":"5561_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2191-219X-2-41","volume":"2","author":"P Lankinen","year":"2012","unstructured":"Lankinen P, Lehtim\u00e4ki K, Hakanen AJ et al (2012) A comparative 18F-FDG PET\/CT imaging of experimental Staphylococcus aureus osteomyelitis and Staphylococcus epidermidis foreign-body-associated infection in the rabbit tibia. EJNMMI Res 2:1\u201310. https:\/\/doi.org\/10.1186\/2191-219X-2-41","journal-title":"EJNMMI Res"},{"key":"5561_CR63","doi-asserted-by":"publisher","DOI":"10.1097\/01.BLO.0000533624.79802.E1","volume":"476","author":"R Mills","year":"2018","unstructured":"Mills R, Cheng TL, Mikulec K et al (2018) CSA-90 promotes bone formation and mitigates methicillin-resistant Staphylococcus aureus infection in a rat open fracture model. Clin Orthop Relat Res 476:1311. https:\/\/doi.org\/10.1097\/01.BLO.0000533624.79802.E1","journal-title":"Clin Orthop Relat Res"},{"key":"5561_CR64","doi-asserted-by":"publisher","first-page":"Page531","DOI":"10.3390\/BIOMEDICINES9050531","volume":"9","author":"T Such\u00fd","year":"2021","unstructured":"Such\u00fd T, Vi\u0161tejnov\u00e1 L, \u0160upov\u00e1 M et al (2021) Vancomycin-loaded collagen\/hydroxyapatite layers electrospun on 3D printed titanium implants prevent bone destruction associated with S. epidermidis infection and enhance osseointegration. Biomedicines 9:Page531-9531. https:\/\/doi.org\/10.3390\/BIOMEDICINES9050531","journal-title":"Biomedicines"},{"key":"5561_CR65","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/JOR.24512","volume":"38","author":"T Tomizawa","year":"2020","unstructured":"Tomizawa T, Ishikawa M, Bello-Irizarry SN et al (2020) Biofilm producing Staphylococcus epidermidis (RP62A strain) inhibits osseous integration without osteolysis and histopathology in a murine septic implant model. Journal of Orthopaedic Research 38:852\u2013860. https:\/\/doi.org\/10.1002\/JOR.24512","journal-title":"Journal of Orthopaedic Research"},{"key":"5561_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ph14030231","volume":"14","author":"JB Doub","year":"2021","unstructured":"Doub JB, Ng VY, Wilson E et al (2021) Successful treatment of a recalcitrant Staphylococcus epidermidis prosthetic knee infection with intraoperative bacteriophage therapy. Pharmaceuticals 14:231. https:\/\/doi.org\/10.3390\/ph14030231","journal-title":"Pharmaceuticals"},{"key":"5561_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11050616","volume":"11","author":"JB Doub","year":"2022","unstructured":"Doub JB, Ng VY, Lee M et al (2022) Salphage: salvage bacteriophage therapy for recalcitrant MRSA prosthetic joint infection. Antibiotics 11:616. https:\/\/doi.org\/10.3390\/antibiotics11050616","journal-title":"Antibiotics"},{"key":"5561_CR68","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","volume":"9","author":"JP Pirnay","year":"2024","unstructured":"Pirnay JP, Djebara S, Steurs G et al (2024) Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study. Nat Microbiol 9:1434\u20131453. https:\/\/doi.org\/10.1038\/s41564-024-01705-x","journal-title":"Nat Microbiol"},{"key":"5561_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIBIOTICS14010087","volume":"14","author":"M \u0141usiak-Szelachowska","year":"2025","unstructured":"\u0141usiak-Szelachowska M, Weber-D\u0105browska B, \u017baczek M et al (2025) The appearance of antiphage antibodies in sera of patients treated with phages. Antibiotics 14:14. https:\/\/doi.org\/10.3390\/ANTIBIOTICS14010087","journal-title":"Antibiotics"},{"key":"5561_CR70","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2217\/FMB-2016-0156","volume":"12","author":"M \u0141usiak-Szelachowska","year":"2016","unstructured":"\u0141usiak-Szelachowska M, Zaczek M, Weber-D\u0105browska B et al (2016) Antiphage activity of sera during phage therapy in relation to its outcome. Future Microbiol 12:109\u2013117. https:\/\/doi.org\/10.2217\/FMB-2016-0156","journal-title":"Future Microbiol"},{"key":"5561_CR71","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/s41591-021-01403-9","volume":"27","author":"RM Dedrick","year":"2021","unstructured":"Dedrick RM, Freeman KG, Nguyen JA et al (2021) Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection. Nat Med 27:1357\u20131361. https:\/\/doi.org\/10.1038\/s41591-021-01403-9","journal-title":"Nat Med"},{"key":"5561_CR72","doi-asserted-by":"publisher","DOI":"10.1093\/CID\/CIAC453","volume":"76","author":"RM Dedrick","year":"2022","unstructured":"Dedrick RM, Smith BE, Cristinziano M et al (2022) Phage therapy of Mycobacterium infections: Compassionate use of phages in 20 patients with drug-resistant mycobacterial disease. Clin Infect Dis 76:103. https:\/\/doi.org\/10.1093\/CID\/CIAC453","journal-title":"Clin Infect Dis"},{"key":"5561_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-026-04301-0","author":"F Gordillo Altamirano","year":"2026","unstructured":"Gordillo Altamirano F, Subedi D, Beiers M et al (2026) Cross-reactive anti-prophage antibodies and bacterial heteroresistance implicated in phage therapeutic failure. Nat Med 32:1895\u20131906. https:\/\/doi.org\/10.1038\/s41591-026-04301-0","journal-title":"Nat Med"},{"key":"5561_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-024-47192-w","volume":"15","author":"JD Berkson","year":"2024","unstructured":"Berkson JD, Wate CE, Allen GB et al (2024) Phage-specific immunity impairs efficacy of bacteriophage targeting Vancomycin Resistant Enterococcus in a murine model. Nat Commun 15:1\u201314. https:\/\/doi.org\/10.1038\/s41467-024-47192-w","journal-title":"Nat Commun"},{"key":"5561_CR75","doi-asserted-by":"publisher","first-page":"517794","DOI":"10.3389\/FMICB.2020.00414","volume":"11","author":"MD Rouse","year":"2020","unstructured":"Rouse MD, Stanbro J, Roman JA et al (2020) Impact of Frequent Administration of Bacteriophage on Therapeutic Efficacy in an A. baumannii Mouse Wound Infection Model. Front Microbiol 11:517794. https:\/\/doi.org\/10.3389\/FMICB.2020.00414","journal-title":"Front Microbiol"},{"key":"5561_CR76","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/V10070351","volume":"10","author":"F Oechslin","year":"2018","unstructured":"Oechslin F (2018) Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy. Viruses 10:351. https:\/\/doi.org\/10.3390\/V10070351","journal-title":"Viruses"},{"key":"5561_CR77","doi-asserted-by":"crossref","unstructured":"Miedzybrodzki R, Borysowski J, Weber-Dabrowska B et al (2012) Clinical Aspects of Phage Therapy. Advances in Virus Research. Academic Press Inc., pp 73\u2013121","DOI":"10.1016\/B978-0-12-394438-2.00003-7"},{"issue":"5","key":"5561_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03678-8","volume":"31","author":"BK Chan","year":"2025","unstructured":"Chan BK, Stanley GL, Kortright KE et al (2025) Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis. Nat Med 31(5):5. https:\/\/doi.org\/10.1038\/s41591-025-03678-8","journal-title":"Nat Med"},{"key":"5561_CR79","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/JAC\/DKG331","volume":"52","author":"I Gustafsson","year":"2003","unstructured":"Gustafsson I, Cars O, Andersson DI (2003) Fitness of antibiotic resistant Staphylococcus epidermidis assessed by competition on the skin of human volunteers. J Antimicrob Chemother 52:258\u2013263. https:\/\/doi.org\/10.1093\/JAC\/DKG331","journal-title":"J Antimicrob Chemother"},{"key":"5561_CR80","doi-asserted-by":"publisher","unstructured":"Heckmann ND, Culler MW, Atallah LM et al (2025) Emerging Concepts in Periprosthetic Joint Infection Research: Infection Recurrence and Microbe Persistence. J Arthroplasty 41(6):1813-1821. https:\/\/doi.org\/10.1016\/j.arth.2025.10.033","DOI":"10.1016\/j.arth.2025.10.033"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05561-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-026-05561-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05561-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:34:34Z","timestamp":1789994074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-026-05561-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":80,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5561"],"URL":"https:\/\/doi.org\/10.1007\/s10096-026-05561-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"22 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures involving animals were approved by the Administration of the Republic of Slovenia for Food Safety, Veterinary and Plant Protection of the Ministry of Agriculture, Forestry and Foods, Republic of Slovenia (Permit Number U34401-22\/2022\/5).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Generative AI tools, such as ChatGPT, were used for language editing and improving the clarity of the manuscript. No AI tools were used to generate scientific content, data, or interpretations and all intellectual content, research design, and data analyses were conducted solely by the authors.","order":3,"name":"Ethics","label":"Declaration on the use of\u00a0generative AI and AI-assisted technologies in writing","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}